Winton Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-22,620
| Closed | -$304K | – | 1187 |
|
|
2023
Q1 | $304K | Buy |
22,620
+1,897
| +9% | +$25.5K | 0.02% | 819 |
|
|
2022
Q4 | $256K | Buy |
20,723
+885
| +4% | +$10.9K | 0.02% | 818 |
|
|
2022
Q3 | $277K | Sell |
19,838
-2,422
| -11% | -$33.8K | 0.02% | 819 |
|
|
2022
Q2 | $307K | Buy |
22,260
+4,900
| +28% | +$67.6K | 0.02% | 801 |
|
|
2022
Q1 | $282K | Buy |
17,360
+3,486
| +25% | +$56.6K | 0.01% | 833 |
|
|
2021
Q4 | $226K | Buy |
+13,874
| New | +$226K | 0.01% | 918 |
|
|
2021
Q3 | – | Sell |
-15,664
| Closed | -$313K | – | 1511 |
|
|
2021
Q2 | $313K | Buy |
15,664
+3,101
| +25% | +$62K | 0.02% | 1155 |
|
|
2021
Q1 | $290K | Buy |
+12,563
| New | +$290K | 0.02% | 1156 |
|